Literature DB >> 30373891

The Evasive Enemy: Insights into the Virulence and Epidemiology of the Emerging Attaching and Effacing Pathogen Escherichia albertii.

Shantanu Bhatt1, Marisa Egan2,3, Brian Critelli2, Andrew Kouse4, Daniel Kalman5, Chirag Upreti6.   

Abstract

The diarrheic attaching and effacing (A/E) pathogen Escherichia albertii was first isolated from infants in Bangladesh in 1991, although the bacterium was initially classified as Hafnia alvei Subsequent genetic and biochemical interrogation of these isolates raised concerns about their initial taxonomic placement. It was not until 2003 that these isolates were reassigned to the novel taxon Escherichia albertii because they were genetically more closely related to E. coli, although they had diverged sufficiently to warrant a novel species name. Unfortunately, new isolates continue to be mistyped as enteropathogenic E. coli (EPEC) or enterohemorrhagic E. coli (EHEC) owing to shared traits, most notably the ability to form A/E lesions. Consequently, E. albertii remains an underappreciated A/E pathogen, despite multiple reports demonstrating that many provisional EPEC and EHEC isolates incriminated in disease outbreaks are actually E. albertii Metagenomic studies on dozens of E. albertii isolates reveal a genetic architecture that boasts an arsenal of candidate virulence factors to rival that of its better-characterized cousins, EPEC and EHEC. Beyond these computational comparisons, studies addressing the regulation, structure, function, and mechanism of action of its repertoire of virulence factors are lacking. Thus, the paucity of knowledge about the epidemiology, virulence, and antibiotic resistance of E. albertii, coupled with its misclassification and its ability to develop multidrug resistance in a single step, highlights the challenges in combating this emerging pathogen. This review seeks to synthesize our current but incomplete understanding of the biology of E. albertii.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Escherichia albertiizzm321990; biochemical markers; genetic markers; locus of enterocyte effacement; multidrug resistance; virulence

Mesh:

Substances:

Year:  2018        PMID: 30373891      PMCID: PMC6300623          DOI: 10.1128/IAI.00254-18

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  121 in total

1.  EspA filament-mediated protein translocation into red blood cells.

Authors:  R K Shaw; S Daniell; F Ebel; G Frankel; S Knutton
Journal:  Cell Microbiol       Date:  2001-04       Impact factor: 3.715

2.  Identification of the intimin-binding domain of Tir of enteropathogenic Escherichia coli.

Authors:  M de Grado; A Abe; A Gauthier; O Steele-Mortimer; R DeVinney; B B Finlay
Journal:  Cell Microbiol       Date:  1999-07       Impact factor: 3.715

3.  Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells.

Authors:  B Kenny; R DeVinney; M Stein; D J Reinscheid; E A Frey; B B Finlay
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

4.  A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells.

Authors:  S Knutton; I Rosenshine; M J Pallen; I Nisan; B C Neves; C Bain; C Wolff; G Dougan; G Frankel
Journal:  EMBO J       Date:  1998-04-15       Impact factor: 11.598

5.  A third secreted protein that is encoded by the enteropathogenic Escherichia coli pathogenicity island is required for transduction of signals and for attaching and effacing activities in host cells.

Authors:  L C Lai; L A Wainwright; K D Stone; M S Donnenberg
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

6.  Isolation of Escherichia albertii from Raw Chicken Liver in Fukuoka City, Japan.

Authors:  Nanami Asoshima; Masanori Matsuda; Kumiko Shigemura; Mikiko Honda; Hidehiro Yoshida; Takahiro Oda; Hiroshi Hiwaki
Journal:  Jpn J Infect Dis       Date:  2015       Impact factor: 1.362

7.  Characterization of Escherichia fergusonii and Escherichia albertii isolated from water.

Authors:  A F Maheux; D K Boudreau; M G Bergeron; M J Rodriguez
Journal:  J Appl Microbiol       Date:  2014-06-11       Impact factor: 3.772

8.  Shiga toxin subtypes display dramatic differences in potency.

Authors:  Cynthia A Fuller; Christine A Pellino; Michael J Flagler; Jane E Strasser; Alison A Weiss
Journal:  Infect Immun       Date:  2011-01-03       Impact factor: 3.441

Review 9.  LEEways: tales of EPEC, ATEC and EHEC.

Authors:  M Alexander Schmidt
Journal:  Cell Microbiol       Date:  2010-08-31       Impact factor: 3.715

10.  Real-time analysis of effector translocation by the type III secretion system of enteropathogenic Escherichia coli.

Authors:  Erez Mills; Kobi Baruch; Xavier Charpentier; Simi Kobi; Ilan Rosenshine
Journal:  Cell Host Microbe       Date:  2008-02-14       Impact factor: 21.023

View more
  7 in total

1.  Atypical Enteropathogenic Escherichia coli: from Kittens to Humans and Beyond!

Authors:  Shantanu Bhatt
Journal:  Infect Immun       Date:  2021-02-16       Impact factor: 3.441

Review 2.  Microbiology and Epidemiology of Escherichia albertii-An Emerging Elusive Foodborne Pathogen.

Authors:  Francis Muchaamba; Karen Barmettler; Andrea Treier; Kurt Houf; Roger Stephan
Journal:  Microorganisms       Date:  2022-04-22

Review 3.  The Changing Face of the Family Enterobacteriaceae (Order: "Enterobacterales"): New Members, Taxonomic Issues, Geographic Expansion, and New Diseases and Disease Syndromes.

Authors:  J Michael Janda; Sharon L Abbott
Journal:  Clin Microbiol Rev       Date:  2021-02-24       Impact factor: 26.132

4.  Prevalence of Escherichia albertii in Raccoons (Procyon lotor), Japan.

Authors:  Atsushi Hinenoya; Keigo Nagano; Sharda P Awasthi; Noritoshi Hatanaka; Shinji Yamasaki
Journal:  Emerg Infect Dis       Date:  2020-06       Impact factor: 6.883

5.  Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial.

Authors:  Harry Pickering; John D Hart; Sarah Burr; Richard Stabler; Ken Maleta; Khumbo Kalua; Robin L Bailey; Martin J Holland
Journal:  Gut Pathog       Date:  2022-01-06       Impact factor: 4.181

6.  CesL Regulates Type III Secretion Substrate Specificity of the Enteropathogenic E. coli Injectisome.

Authors:  Miguel Díaz-Guerrero; Meztlli O Gaytán; Eduardo Soto; Norma Espinosa; Elizabeth García-Gómez; Arely Marcos-Vilchis; Angel Andrade; Bertha González-Pedrajo
Journal:  Microorganisms       Date:  2021-05-13

7.  Advances and Challenges in Studying Type III Secretion Effectors of Attaching and Effacing Pathogens.

Authors:  Sabrina L Slater; Gad Frankel
Journal:  Front Cell Infect Microbiol       Date:  2020-07-07       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.